Bristlecone Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-556
Closed -$277K 364
2025
Q1
$277K Sell
556
-12
-2% -$5.97K 0.02% 245
2024
Q4
$295K Hold
568
0.02% 242
2024
Q3
$351K Hold
568
0.03% 220
2024
Q2
$314K Hold
568
0.03% 227
2024
Q1
$330K Sell
568
-10
-2% -$5.81K 0.03% 222
2023
Q4
$307K Sell
578
-40
-6% -$21.2K 0.03% 224
2023
Q3
$313K Hold
618
0.04% 207
2023
Q2
$322K Buy
618
+40
+7% +$20.9K 0.03% 210
2023
Q1
$333K Buy
578
+50
+9% +$28.8K 0.04% 209
2022
Q4
$291K Buy
528
+21
+4% +$11.6K 0.04% 211
2022
Q3
$257K Buy
507
+49
+11% +$24.8K 0.03% 214
2022
Q2
$249K Hold
458
0.03% 213
2022
Q1
$271K Hold
458
0.03% 201
2021
Q4
$306K Hold
458
0.04% 190
2021
Q3
$262K Hold
458
0.03% 191
2021
Q2
$231K Sell
458
-10
-2% -$5.04K 0.03% 202
2021
Q1
$214K Sell
468
-32
-6% -$14.6K 0.03% 201
2020
Q4
$233K Buy
+500
New +$233K 0.04% 186
2020
Q1
Sell
-1,416
Closed -$460K 200
2019
Q4
$460K Buy
+1,416
New +$460K 0.09% 138
2019
Q3
Sell
-1,248
Closed -$367K 178
2019
Q2
$367K Buy
+1,248
New +$367K 0.09% 140
2018
Q4
Sell
-1,289
Closed -$315K 146
2018
Q3
$315K Buy
1,289
+40
+3% +$9.78K 0.08% 126
2018
Q2
$259K Sell
1,249
-10
-0.8% -$2.07K 0.09% 114
2018
Q1
$260K Buy
1,259
+39
+3% +$8.05K 0.09% 122
2017
Q4
$232K Buy
1,220
+15
+1% +$2.85K 0.07% 132
2017
Q3
$228K Hold
1,205
0.07% 133
2017
Q2
$210K Buy
+1,205
New +$210K 0.07% 141
2017
Q1
Sell
-1,665
Closed -$235K 156
2016
Q4
$235K Sell
1,665
-3,340
-67% -$471K 0.08% 136
2016
Q3
$796K Sell
5,005
-500
-9% -$79.5K 0.29% 88
2016
Q2
$813K Sell
5,505
-215
-4% -$31.8K 0.3% 82
2016
Q1
$810K Buy
5,720
+2,400
+72% +$340K 0.32% 78
2015
Q4
$471K Buy
+3,320
New +$471K 0.2% 112